ClinicalTrials.Veeva

Menu
T

Texas Retina Associates | Plano, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-301
Aflibercept
OCS-01
EYP-1901
Yutiq
AIV007
Tarcocimab

Parent organization

This site is a part of Texas Retina Associates

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 12 total trials

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Enrolling
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (...

Enrolling
Wet Age-related Macular Degeneration
Drug: Tarcocimab tedromer
Drug: Aflibercept

This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with DR.

Active, not recruiting
Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection

To determine safety, pharmacokinetics, and duration of effect of periocularly administered AIV007 gel suspension in subjects with neovascular age-rel...

Active, not recruiting
Diabetic Macular Edema
Macular Edema
Drug: AIV007
Status recently updated

The goal of the LEOPARD clinical trial is to investigate a new kind of steroid eye drops, OCS-01.Macular edema is a condition in which there is colle...

Enrolling
Active, not recruiting
Uveitis Related Cystoid Macular Edema
Cystoid Macular Edema, Postoperative
Drug: OCS-01

Trial sponsors

Kodiak Sciences logo
A
C
E
Q
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems